Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro

Journal name:
Nature
Volume:
470,
Pages:
105–109
Date published:
DOI:
doi:10.1038/nature09691
Received
Accepted
Published online

Studies in embryonic development have guided successful efforts to direct the differentiation of human embryonic and induced pluripotent stem cells (PSCs) into specific organ cell types in vitro1, 2. For example, human PSCs have been differentiated into monolayer cultures of liver hepatocytes and pancreatic endocrine cells3, 4, 5, 6 that have therapeutic efficacy in animal models of liver disease7, 8 and diabetes9, respectively. However, the generation of complex three-dimensional organ tissues in vitro remains a major challenge for translational studies. Here we establish a robust and efficient process to direct the differentiation of human PSCs into intestinal tissue in vitro using a temporal series of growth factor manipulations to mimic embryonic intestinal development10. This involved activin-induced definitive endoderm formation11, FGF/Wnt-induced posterior endoderm pattering, hindgut specification and morphogenesis12, 13, 14, and a pro-intestinal culture system15, 16 to promote intestinal growth, morphogenesis and cytodifferentiation. The resulting three-dimensional intestinal ‘organoids’ consisted of a polarized, columnar epithelium that was patterned into villus-like structures and crypt-like proliferative zones that expressed intestinal stem cell markers17. The epithelium contained functional enterocytes, as well as goblet, Paneth and enteroendocrine cells. Using this culture system as a model to study human intestinal development, we identified that the combined activity of WNT3A and FGF4 is required for hindgut specification whereas FGF4 alone is sufficient to promote hindgut morphogenesis. Our data indicate that human intestinal stem cells form de novo during development. We also determined that NEUROG3, a pro-endocrine transcription factor that is mutated in enteric anendocrinosis18, is both necessary and sufficient for human enteroendocrine cell development in vitro. PSC-derived human intestinal tissue should allow for unprecedented studies of human intestinal development and disease.

At a glance

Figures

  1. FGF4 and WNT3A act synergistically in a temporal and dose-dependent manner to specify stable posterior endoderm fate.
    Figure 1: FGF4 and WNT3A act synergistically in a temporal and dose-dependent manner to specify stable posterior endoderm fate.

    ad, Activin A (100ngml−1) was used to differentiate H9 human ES cells into definitive endoderm. Definitive endoderm was treated with the posteriorizing factors FGF4 (50 or 500ng), WNT3A (50 or 500ng), or both for 6, 48 or 96h. Cells were placed in permissive media for 7 days and expression of foregut markers (ALB, PDX1) and the hindgut marker (CDX2) were analysed by RT–qPCR (a) and immunofluorescence (bd). The definitive endoderm of controls was grown for identical lengths of time in the absence of FGF4 or WNT3A. High levels of FGF4+WNT3A for 96h resulted in stable CDX2 expression and lack of foregut marker expression. Scale bars, 50μm. Error bars are s.e.m. (n = 3). *P<0.05, **P<0.001, ***P<0.0001.

  2. Morphogenesis of posterior endoderm into three-dimensional, hindgut-like spheroids.
    Figure 2: Morphogenesis of posterior endoderm into three-dimensional, hindgut-like spheroids.

    a, Bright-field images of definitive endoderm cultured for 96h in media, FGF4, WNT3A or FGF4+WNT3A. FGF4+WNT3A cultures contained three-dimensional epithelial tubes and free-floating spheres (black arrows) b, CDX2 immunostaining (green) and nuclear stain (DRAQ5, blue) on cultures shown in a. Insets show CDX2 staining alone. c, Bright-field image of hindgut-like spheroids. ac, Scale bars, 50μm. df, Analysis of CDX2, basal-lateral laminin and E-cadherin expression demonstrates an inner layer of polarized, cuboidal, CDX2+ epithelium surrounded by non-polarized mesenchymal CDX2+ cells. Scale bar in e is 20μm.g, CDX2 expression in an e8.5 mouse embryo (sagittal section). Inset is a magnified view showing that both hindgut endoderm (E; outlined with a red dashed line) and adjacent mesenchyme (M) are CDX2 positive (green). FG, foregut; HG, hindgut. Scale bar, 100μm.

  3. Human ES cells and iPSCs form three-dimensional intestine-like organoids.
    Figure 3: Human ES cells and iPSCs form three-dimensional intestine-like organoids.

    a, A time course shows that intestinal organoids formed highly convoluted epithelial structures surrounded by mesenchyme after 13 days (d). be, Intestinal transcription factor expression (KLF5, CDX2, SOX9) and cell proliferation on serial sections of organoids after 14 and 28 days (serial sections are b and c, d and e). Ki67, nuclear proliferation antigen. Nuc, nuclei. f, g, Expression of KLF5, CDX2, and SOX9 in mouse fetal intestine at e14.5 (f) and e16.5 (g) is similar to developing intestinal organoids. The right panels show separate colour channels for d, e and g (bracket highlights the region shown in the panels on the right). hj, Whole mount in situ hybridization of 56-day-old organoids showing epithelial expression of SOX9 (h) and restricted ‘crypt-like’ expression of the stem cell markers LGR5 (i) and ASCL2 (j). Insets show sense controls for each probe. Scale bars, 20μm.

  4. Formation and function of intestinal cell types and regulation of enteroendocrine differentiation by NEUROG3.
    Figure 4: Formation and function of intestinal cell types and regulation of enteroendocrine differentiation by NEUROG3.

    ac, Twenty-eight-day iPSC-derived organoids were analysed for villin (VIL) and the goblet cell marker mucin (MUC2) (a), the Paneth cell marker lysozyme (LYZ) (b), or the endocrine cell marker chromogranin A (CHGA) (c). Nuc, nuclei. d, Electron micrograph showing an enterocyte cell with a characteristic brush border with microvilli (inset). e, Epithelial uptake of the fluorescently labelled dipeptide d-Ala-Lys-AMCA (arrowheads) indicating a functional peptide transport system. fh, Adenoviral expression of NEUROG3 (Ad-NEUROG3) causes a fivefold increase in CGA+ cells compared to a GFP control (Ad-GFP). n = 4 biological samples;*P = 0.005. ik, Organoids were generated from human ES cells that were stably transduced with shRNA-expressing lentiviral vectors. Compared to control shRNA organoids, NEUROG3 shRNA organoids had a 95% reduction in the number of CHGA+ cells. n = 3 for shRNA controls and n = 5 for NEUROG3-shRNA; *P = 0.018. Scale bar in a is 10μm; all others are 20μm.Error bars are s.e.m.

Accession codes

Primary accessions

Gene Expression Omnibus

References

  1. Mayhew, C. N. & Wells, J. M. Converting human pluripotent stem cells into β-cells: recent advances and future challenges. Curr. Opin. Organ Transplant. 15, 5460 (2010)
  2. Spence, J. R. & Wells, J. M. Translational embryology: using embryonic principles to generate pancreatic endocrine cells from embryonic stem cells. Dev. Dyn. 236, 32183227 (2007)
  3. Cai, J. et al. Directed differentiation of human embryonic stem cells into functional hepatic cells. Hepatology 45, 12291239 (2007)
  4. D’Amour, K. A. et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nature Biotechnol. 24, 13921401 (2006)
  5. Song, Z. et al. Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells. Cell Res. 19, 12331242 (2009)
  6. Zhang, D. et al. Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells. Cell Res. 19, 429438 (2009)
  7. Basma, H. et al. Differentiation and transplantation of human embryonic stem cell-derived hepatocytes. Gastroenterology 136, 990999 (2008)
  8. Touboul, T. et al. Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development. Hepatology 51, 17541765 (2010)
  9. Kroon, E. et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo . Nature Biotechnol. 26, 443452 (2008)
  10. Zorn, A. M. & Wells, J. M. Vertebrate endoderm development and organ formation. Annu. Rev. Cell Dev. Biol. 25, 221251 (2009)
  11. D’Amour, K. A. et al. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nature Biotechnol. 23, 15341541 (2005)
  12. Dessimoz, J., Opoka, R., Kordich, J. J., Grapin-Botton, A. & Wells, J. M. FGF signaling is necessary for establishing gut tube domains along the anterior-posterior axis in vivo . Mech. Dev. 123, 4255 (2006)
  13. McLin, V. A., Rankin, S. A. & Zorn, A. M. Repression of Wnt/β-catenin signaling in the anterior endoderm is essential for liver and pancreas development. Development 134, 22072217 (2007)
  14. Wells, J. M. & Melton, D. A. Early mouse endoderm is patterned by soluble factors from adjacent germ layers. Development 127, 15631572 (2000)
  15. Gracz, A. D., Ramalingam, S. & Magness, S. T. Sox9 expression marks a subset of CD24-expressing small intestine epithelial stem cells that form organoids in vitro . Am. J. Physiol. Gastrointest. Liver Physiol. 298, G590G600 (2010)
  16. Sato, T. et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459, 262265 (2009)
  17. de Santa Barbara, P., van den Brink, G. R. & Roberts, D. J. Development and differentiation of the intestinal epithelium. Cell. Mol. Life Sci. 60, 13221332 (2003)
  18. Wang, J. et al. Mutant neurogenin-3 in congenital malabsorptive diarrhea. N. Engl. J. Med. 355, 270280 (2006)
  19. Cao, L. et al. Intestinal lineage commitment of embryonic stem cells. Differentiation doi:10.1016/j.diff.2010.09.182 (in the press)
  20. Torihashi, S. et al. Gut-like structures from mouse embryonic stem cells as an in vitro model for gut organogenesis preserving developmental potential after transplantation. Stem Cells 24, 26182626 (2006)
  21. van der Flier, L. G. et al. Transcription factor achaete scute-like 2 controls intestinal stem cell fate. Cell 136, 903912 (2009)
  22. Groneberg, D. A., Doring, F., Eynott, P. R., Fischer, A. & Daniel, H. Intestinal peptide transport: ex vivo uptake studies and localization of peptide carrier PEPT1. Am. J. Physiol. Gastrointest. Liver Physiol. 281, G697G704 (2001)
  23. Haveri, H. et al. Transcription factors GATA-4 and GATA-6 in normal and neoplastic human gastrointestinal mucosa. BMC Gastroenterol. 8, 9 (2008)
  24. McLin, V. A., Henning, S. J. & Jamrich, M. The role of the visceral mesoderm in the development of the gastrointestinal tract. Gastroenterology 136, 20742091 (2009)
  25. Ormestad, M. et al. Foxf1 and Foxf2 control murine gut development by limiting mesenchymal Wnt signaling and promoting extracellular matrix production. Development 133, 833843 (2006)
  26. Kosinski, C. et al. Indian hedgehog regulates intestinal stem cell fate through epithelial-mesenchymal interactions during development. Gastroenterology 139, 893903 (2010)
  27. Jenny, M. et al. Neurogenin3 is differentially required for endocrine cell fate specification in the intestinal and gastric epithelium. EMBO J. 21, 63386347 (2002)
  28. Lee, C. S., Perreault, N., Brestelli, J. E. & Kaestner, K. H. Neurogenin 3 is essential for the proper specification of gastric enteroendocrine cells and the maintenance of gastric epithelial cell identity. Genes Dev. 16, 14881497 (2002)
  29. Lopez-Diaz, L. et al. Intestinal Neurogenin 3 directs differentiation of a bipotential secretory progenitor to endocrine cell rather than goblet cell fate. Dev. Biol. 309, 298305 (2007)
  30. Ootani, A. et al. Sustained in vitro intestinal epithelial culture within a Wnt-dependent stem cell niche. Nature Med. 15, 701706 (2009)
  31. Zhou, Q., Brown, J., Kanarek, A., Rajagopal, J. & Melton, D. A. In vivo reprogramming of adult pancreatic exocrine cells to β-cells. Nature 455, 627632 (2008)
  32. Ludwig, T. E. et al. Feeder-independent culture of human embryonic stem cells. Nature Methods 3, 637646 (2006)
  33. Ludwig, T. E. et al. Derivation of human embryonic stem cells in defined conditions. Nature Biotechnol. 24, 185187 (2006)
  34. Lambert, P. F. et al. Using an immortalized cell line to study the HPV life cycle in organotypic “raft” cultures. Methods Mol. Med. 119, 141155 (2005)
  35. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861872 (2007)
  36. Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663676 (2006)
  37. Richards, M., Tan, S. P., Tan, J. H., Chan, W. K. & Bongso, A. The transcriptome profile of human embryonic stem cells as defined by SAGE. Stem Cells 22, 5164 (2004)
  38. Thomson, J. A. et al. Embryonic stem cell lines derived from human blastocysts. Science 282, 11451147 (1998)

Download references

Author information

Affiliations

  1. Division of Developmental Biology, Cincinnati Children’s Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, Ohio 45229-3039, USA

    • Jason R. Spence,
    • Christopher N. Mayhew,
    • Scott A. Rankin,
    • Matthew F. Kuhar,
    • Kathryn Tolle,
    • Vladimir V. Kalinichenko,
    • Aaron M. Zorn,
    • Noah F. Shroyer &
    • James M. Wells
  2. Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children’s Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, Ohio 45229-3039, USA

    • Jefferson E. Vallance &
    • Noah F. Shroyer
  3. Division of Hematology and Oncology Cincinnati Children’s Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, Ohio 45229-3039, USA

    • Elizabeth E. Hoskins &
    • Susanne I. Wells
  4. Division of Pulmonary Biology, Cincinnati Children’s Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, Ohio 45229-3039, USA

    • Vladimir V. Kalinichenko

Contributions

J.M.W. and J.R.S. conceived the study and experimental design, performed and analysed experiments and co-wrote the manuscript. S.A.R., M.F.K. and J.E.V. performed experiments. C.N.M., M.F.K., K.T., V.V.K., J.E.V., E.E.H. and S.I.W. provided reagents, conceptual and/or technical support in generating and characterizing iPSC lines and intestinal organoids. N.F.S. and A.M.Z. provided additional conceptual and experimental support and co-funded the project. All authors read and approved the final manuscript.

Competing financial interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to:

Data have been deposited at NCBI under accession number GSE25557.

Author details

Supplementary information

PDF files

  1. Supplementary Information (15M)

    This file contains Supplementary Figures 1-15 with legends, Supplementary Tables 1-3 and additional references.

Additional data